Lantern Pharma Inc.·4

Jun 15, 5:14 PM ET

KEYSER D JEFFREY 4

4 · Lantern Pharma Inc. · Filed Jun 15, 2020

Insider Transaction Report

Form 4
Period: 2020-06-11
Transactions
  • Purchase

    Common Stock

    2020-06-11$15.00/sh+10,000$150,00010,000 total
Footnotes (1)
  • [F1]The 10,000 shares of common stock were purchased by the Reporting Person at the offering price $15.00 per share for a total purchase price of $150,000, in connection with Issuer's initial public offering which closed on June 15, 2020. The Reporting Person received notification of the order on June 11, 2020.

Documents

1 file
  • 4
    ownership.xmlPrimary

    OWNERSHIP DOCUMENT